NICE’s Forxiga Reversal For Diabetes 2 Restricts Treatment Regimens
This article was originally published in The Pink Sheet Daily
Executive Summary
Reversing a previous stance, NICE has now agreed to recommend BMS/AZ’s Forxiga for diabetes type 2, though questions concerning data on combination regimens led to restrictions.